Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 1,500,000 | 1,000,000 | -500,000 | $280.92M | $130.34M | 7.97% | -$150.58M |
| Insmed Incorporated(INSM) | 1,600,000 | 1,600,000 | 0 | $170.59M | $128.98M | 7.89% | -$41.61M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,000,000 | 2,400,000 | +400,000 | $81.26M | $97.44M | 5.96% | +$16.18M |
| Cytokinetics, Incorporated(CYTK) | 1,600,000 | 1,600,000 | 0 | $136.30M | $72.50M | 4.43% | -$63.80M |
| Merck & Co., Inc.(MRK) | 350,000 | 450,000 | +100,000 | $44.98M | $65.39M | 4.00% | +$20.41M |
| Scholar Rock Holding Corporation(SRRK) | 750,000 | 1,255,000 | +505,000 | $41.25M | $60.64M | 3.71% | +$19.39M |
| Centene Corporation(CNC) | 300,000 | 750,000 | +450,000 | $19.26M | $46.59M | 2.85% | +$27.33M |
| Axsome Therapeutics, Inc.(AXSM) | 300,000 | 250,000 | -50,000 | $73.43M | $46.10M | 2.82% | -$27.33M |
| Vera Therapeutics, Inc.CL A(VERA) | 1,750,000 | 1,500,000 | -250,000 | $75.09M | $32.29M | 1.97% | -$42.80M |
| Amgen Inc.(AMGN) | 0 | 75,000 | +75,000 | $0 | $31.61M | 1.93% | +$31.61M |
| LifeStance Health Group, Inc.(LFST) | 3,000,000 | 2,600,000 | -400,000 | $32.13M | $31.28M | 1.91% | -$852.0K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 40,000 | 40,000 | 0 | $24.94M | $30.33M | 1.85% | +$5.39M |
| Tenet Healthcare Corporation(THC) | 165,000 | 90,000 | -75,000 | $30.87M | $23.00M | 1.41% | -$7.87M |
| Biogen Inc.(BIIB) | 100,000 | 100,000 | 0 | $21.61M | $22.59M | 1.38% | +$982.0K |
| Tango Therapeutics, Inc.(TNGX) | 1,000,000 | 1,000,000 | 0 | $31.26M | $22.45M | 1.37% | -$8.80M |
| Cardinal Health, Inc.(CAH) | 300,000 | 100,000 | -200,000 | $71.27M | $22.25M | 1.36% | -$49.02M |
| CVS Health Corporation(CVS) | 1,100,000 | 500,000 | -600,000 | $113.80M | $21.42M | 1.31% | -$92.37M |
| Neurocrine Biosciences, Inc.(NBIX) | 150,000 | 150,000 | 0 | $25.28M | $21.28M | 1.30% | -$4.00M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 40,000 | 40,000 | 0 | $19.87M | $20.91M | 1.28% | +$1.04M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,900,000 | 1,700,000 | -200,000 | $20.58M | $20.20M | 1.24% | -$372.0K |
| BridgeBio Pharma, Inc.(BBIO) | 275,000 | 300,000 | +25,000 | $20.48M | $19.74M | 1.21% | -$742.0K |
| Incyte Corporation(INCY) | 0 | 160,000 | +160,000 | $0 | $19.42M | 1.19% | +$19.42M |
| Definium Therapeutics, Inc.(DFTX) | 550,000 | 500,000 | -50,000 | $25.87M | $19.03M | 1.16% | -$6.84M |
| BrightSpring Health Services, Inc.(BTSG) | 550,000 | 325,000 | -225,000 | $38.36M | $18.44M | 1.13% | -$19.91M |
| BeOne Medicines AGADS(ONC) | 0 | 50,000 | +50,000 | $0 | $18.30M | 1.12% | +$18.30M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,000,000 | 2,000,000 | 0 | $70.78M | $18.29M | 1.12% | -$52.49M |
| LB Pharmaceuticals Inc(LBRX) | 150,000 | 470,000 | +320,000 | $4.87M | $18.04M | 1.10% | +$13.17M |
| Becton, Dickinson and Company(BDX) | 0 | 100,000 | +100,000 | $0 | $17.90M | 1.09% | +$17.90M |
| Boston Scientific Corporation(BSX) | 900,000 | 400,000 | -500,000 | $38.41M | $17.46M | 1.07% | -$20.95M |
| Edwards Lifesciences Corp | 625,000 | 200,000 | -425,000 | $56.54M | $17.26M | 1.06% | -$39.27M |
| Erasca, Inc.(ERAS) | 1,000,000 | 1,130,000 | +130,000 | $18.32M | $16.57M | 1.01% | -$1.75M |
| Alkermes plcSHS(ALKS) | 100,000 | 375,000 | +275,000 | $5.24M | $15.20M | 0.93% | +$9.96M |
| Medtronic plcSHS(MDT) | 200,000 | 175,000 | -25,000 | $15.65M | $15.10M | 0.92% | -$545.3K |
| Glaukos Corporation(GKOS) | 150,000 | 90,000 | -60,000 | $20.96M | $14.78M | 0.90% | -$6.19M |
| Encompass Health Corporation(EHC) | 0 | 120,000 | +120,000 | $0 | $14.58M | 0.89% | +$14.58M |
| Novartis AGADR(NVS) | 200,000 | 100,000 | -100,000 | $31.34M | $14.26M | 0.87% | -$17.09M |
| Absci Corporation | 800,000 | 1,300,000 | +500,000 | $9.27M | $14.00M | 0.86% | +$4.73M |
| Quest Diagnostics Incorporated(DGX) | 200,000 | 55,000 | -145,000 | $42.39M | $12.82M | 0.78% | -$29.57M |
| Alto Neuroscience, Inc.(ANRO) | 500,000 | 500,000 | 0 | $13.20M | $12.77M | 0.78% | -$430.0K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 25,000 | 25,000 | 0 | $13.42M | $12.60M | 0.77% | -$824.8K |
| Bristol-Myers Squibb Company(BMY) | 0 | 200,000 | +200,000 | $0 | $12.48M | 0.76% | +$12.48M |
| uniQure N.V.SHS(QURE) | 900,000 | 500,000 | -400,000 | $41.45M | $12.08M | 0.74% | -$29.37M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 550,000 | 250,000 | -300,000 | $61.07M | $11.90M | 0.73% | -$49.16M |
| Teva Pharmaceutical Inds LtdSHS | 0 | 300,000 | +300,000 | $0 | $11.88M | 0.73% | +$11.88M |
| Travere Therapeutics, Inc.(TVTX) | 375,000 | 200,000 | -175,000 | $21.30M | $11.78M | 0.72% | -$9.53M |
| Praxis Precision Medicines, Inc.(PRAX) | 40,000 | 40,000 | 0 | $13.39M | $11.65M | 0.71% | -$1.74M |
| LivaNova PLCNOTE 2 500 3 1(LIVN) | 0 | 150,000 | +150,000 | $0 | $11.47M | 0.70% | +$11.47M |
| Waters Corporation(WAT) | 40,000 | 25,000 | -15,000 | $15.00M | $10.98M | 0.67% | -$4.02M |
| Surrozen, Inc.(SRZN) | 0 | 325,000 | +325,000 | $0 | $10.46M | 0.64% | +$10.46M |
| Inspire Medical Systems, Inc.(INSP) | 100,000 | 150,000 | +50,000 | $4.46M | $10.40M | 0.64% | +$5.94M |
| Mineralys Therapeutics, Inc.(MLYS) | 450,000 | 400,000 | -50,000 | $12.14M | $10.05M | 0.61% | -$2.09M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 455,000 | +455,000 | $0 | $9.95M | 0.61% | +$9.95M |
| Thermo Fisher Scientific Inc.(TMO) | 0 | 14,000 | +14,000 | $0 | $9.45M | 0.58% | +$9.45M |
| REGENXBIO Inc.(RGNX) | 800,000 | 1,200,000 | +400,000 | $9.58M | $9.04M | 0.55% | -$548.0K |
| Spyre Therapeutics, Inc.(SYRE) | 325,000 | 325,000 | 0 | $28.85M | $8.90M | 0.54% | -$19.95M |
| Ovid Therapeutics Inc.(OVID) | 0 | 3,500,000 | +3,500,000 | $0 | $8.71M | 0.53% | +$8.71M |
| The Cooper Companies, Inc.(COO) | 0 | 150,000 | +150,000 | $0 | $8.48M | 0.52% | +$8.48M |
| Climb Bio, Inc.(CLYM) | 0 | 700,000 | +700,000 | $0 | $8.03M | 0.49% | +$8.03M |
| Attovia Therapeutics Inc | 0 | 450,000 | +450,000 | $0 | $7.71M | 0.47% | +$7.71M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 30,000 | +30,000 | $0 | $7.40M | 0.45% | +$7.40M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 240,000 | +240,000 | $0 | $7.14M | 0.44% | +$7.14M |
| Guardant Health, Inc.(GH) | 0 | 40,000 | +40,000 | $0 | $7.13M | 0.44% | +$7.13M |
| TG Therapeutics, Inc.(TGTX) | 0 | 125,000 | +125,000 | $0 | $6.97M | 0.43% | +$6.97M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 150,000 | +150,000 | $0 | $6.70M | 0.41% | +$6.70M |
| Vor Biopharma Inc.(VOR) | 0 | 350,000 | +350,000 | $0 | $6.68M | 0.41% | +$6.68M |
| Cogent Biosciences, Inc.(COGT) | 200,000 | 200,000 | 0 | $7.74M | $6.40M | 0.39% | -$1.34M |
| 10x Genomics, Inc.CL A(TXG) | 0 | 70,000 | +70,000 | $0 | $6.33M | 0.39% | +$6.33M |
| Helus Pharma Inc(HELP) | 0 | 500,000 | +500,000 | $0 | $6.14M | 0.38% | +$6.14M |
| Immatics N.V.SHS(IMTX) | 0 | 690,000 | +690,000 | $0 | $6.06M | 0.37% | +$6.06M |
| Sana Biotechnology, Inc.(SANA) | 2,000,000 | 2,000,000 | 0 | $6.98M | $5.83M | 0.36% | -$1.15M |
| COMPASS Pathways plcADS(CMPS) | 0 | 460,000 | +460,000 | $0 | $5.72M | 0.35% | +$5.72M |
| Neurogene Inc.(NGNE) | 0 | 200,000 | +200,000 | $0 | $5.56M | 0.34% | +$5.56M |
| Alumis Inc | 700,000 | 700,000 | 0 | $19.70M | $5.17M | 0.32% | -$14.53M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 50,000 | +50,000 | $0 | $4.95M | 0.30% | +$4.95M |
| Apnimed Inc | 0 | 225,000 | +225,000 | $0 | $4.93M | 0.30% | +$4.93M |
| Beam Therapeutics Inc.(BEAM) | 300,000 | 200,000 | -100,000 | $10.30M | $4.89M | 0.30% | -$5.41M |
| Inventiva S.A.ADS(IVA) | 1,520,000 | 1,300,000 | -220,000 | $5.75M | $4.80M | 0.29% | -$948.6K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 345,000 | +345,000 | $0 | $4.63M | 0.28% | +$4.63M |
| Enliven Therapeutics Inc | 150,000 | 100,000 | -50,000 | $7.61M | $4.58M | 0.28% | -$3.03M |
| Biohaven Ltd.(BHVN) | 700,000 | 300,000 | -400,000 | $10.42M | $4.00M | 0.24% | -$6.41M |
| IDEAYA Biosciences, Inc.(IDYA) | 100,000 | 100,000 | 0 | $3.73M | $3.84M | 0.23% | +$115.0K |
| Protara Therapeutics, Inc.(TARA) | 1,500,000 | 1,250,000 | -250,000 | $5.73M | $3.81M | 0.23% | -$1.92M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 160,000 | +160,000 | $0 | $3.79M | 0.23% | +$3.79M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 300,000 | +300,000 | $0 | $3.58M | 0.22% | +$3.58M |
| Kardigan Inc | 200,000 | 225,000 | +25,000 | $4.77M | $3.32M | 0.20% | -$1.45M |
| Savara Inc.(SVRA) | 600,000 | 600,000 | 0 | $3.70M | $3.10M | 0.19% | -$600.0K |
| Caris Life Sciences, Inc.(CAI) | 0 | 100,000 | +100,000 | $0 | $3.06M | 0.19% | +$3.06M |
| Trevi Therapeutics, Inc.(TRVI) | 200,000 | 200,000 | 0 | $3.73M | $2.86M | 0.18% | -$866.0K |
| Inhibikase Therapeutics, Inc.(IKT) | 1,350,000 | 1,350,000 | 0 | $2.74M | $2.77M | 0.17% | +$33.8K |
| Maze Therapeutics, Inc.(MAZE) | 0 | 100,000 | +100,000 | $0 | $2.72M | 0.17% | +$2.72M |
| AgomAb Therapeutics NVADS(AGMB) | 0 | 235,000 | +235,000 | $0 | $2.61M | 0.16% | +$2.61M |
| Electra Therapeutics Inc | 0 | 200,000 | +200,000 | $0 | $2.25M | 0.14% | +$2.25M |
| Braveheart Bio Inc | 0 | 100,000 | +100,000 | $0 | $2.02M | 0.12% | +$2.02M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 0 | 495,000 | +495,000 | $0 | $2.00M | 0.12% | +$2.00M |
| Aclaris Therapeutics, Inc.(ACRS) | 0 | 200,000 | +200,000 | $0 | $1.05M | 0.06% | +$1.05M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 250,000 | +250,000 | $0 | $725.0K | 0.04% | +$725.0K |
| Abbott Laboratories | 400,000 | 0 | -400,000 | $36.30M | $0 | — | -$36.30M |
| Acadia Healthcare Company, Inc.(ACHC) | 400,000 | 0 | -400,000 | $11.81M | $0 | — | -$11.81M |
| Alignment Healthcare, Inc.(ALHC) | 2,000,000 | 0 | -2,000,000 | $47.62M | $0 | — | -$47.62M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 200,000 | 0 | -200,000 | $16.30M | $0 | — | -$16.30M |